CDK 4/6 Inhibitors as Single Agent in Advanced Solid Tumors

Schettini, F; De Santo, I; Rea, CG; De Placido, P; Formisano, L; Giuliano, M; Arpino, G; De Laurentiis, M; Puglisi, F; De Placido, S; Del Mastro, L

Schettini, F (reprint author), Univ Naples Federico II, Naples, Italy.

FRONTIERS IN ONCOLOGY, 2018; 8 ():

Abstract

Cyclin-dependent kinases (CDK) 4/6 inhibitors, namely abemaciclib, palbociclib, and ribociclib, interfere with cell cycle progression, induce cell sen......

Full Text Link